Experimental drug ampligen targets debilitating fatigue
Disease control
TEMPORARILY_NOT_AVAILABLE
This study tests an experimental drug called Ampligen in people with severe chronic fatigue syndrome (CFS). Participants must have had CFS for at least a year and be between 18 and 70 years old. The goal is to see if Ampligen can help control the disease and reduce symptoms.
Sponsor: AIM ImmunoTech Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC